Successful development of an immunochromatographic kit for detecting SARS-CoV -2 antigen for the diagnosis of a novel coronavirus infection (COVID -19)

Commercialization of New Coronavirus Antigen Rapid Diagnostic Kit
Kohjin Bio Co., Ltd. (President: Takato Nakamura, Head Office: Sakado-shi, Saitama) has successfully developed an immunochromatographic kit for detecting the SARS-CoV -2 antigen for a novel coronavirus infection (COVID -19) in collaboration with a research group in Microbiology, Graduate School of Medicine, Juntendo University (Professor: Teruo Kirikae).